Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Alizapride
2. Alizapride Hydrochloride
3. Litican
4. Ms 5080
5. Ms-5080
6. N-((1-allyl-2-pyrrolidinyl)methyl)-6-methoxy-1h-benzotriazole-5-carboxamide
7. N-((allyl-1-pyrrolidinyl-2)-methyl)methoxy-2-azimido-4,5-benzamide
8. N-(1-allyl-2-pyrrolidinylmethyl)-6-methoxy-1h-benzotriazole-5-carboxamide Hydrochloride
9. Plitican
1. 59338-87-3
2. Limican
3. 41bt72boq7
4. Plitican
5. Nausilen
6. 6-methoxy-n-{[1-(prop-2-en-1-yl)pyrrolidin-2-yl]methyl}-1h-1,2,3-benzotriazole-5-carboxamide Hydrochloride
7. Pliyivsn
8. Alizaprid Hydrochlorid
9. Unii-41bt72boq7
10. Hy-a0125a
11. Dtxsid20974759
12. Alizapride Hydrochloride [mi]
13. Ac-6819
14. Alizapride Hydrochloride [mart.]
15. Alizapride Hydrochloride [who-dd]
16. Cs-0019741
17. Q27258431
18. N-(1-allyl-2-pyrrolidinylmethyl)-6-methoxy-1h-benzotriazole-5-carboxamide Hydrochloride
19. (+/-)-n-(1-allyl-2-pyrrolidinylmethyl)-6-methoxy-1h-benzotriazole-5-carboxamide Hydrochloride
20. 1h-benzotriazole-5-carboxamide, 6-methoxy-n-((1-(2-propenyl)-2-pyrrolidinyl)methyl)-, Monohydrochloride
21. 1h-benzotriazole-5-carboxamide,6-methoxy-n-[[1-(2-propenyl)-2-pyrrolidinyl]methyl]-, Monohydrochloride
22. 5-methoxy-n-{[1-(prop-2-en-1-yl)pyrrolidin-2-yl]methyl}-1h-benzotriazole-6-carboximidic Acid--hydrogen Chloride (1/1)
23. 6-methoxy-n-((1-(2-propen-1-yl)-2-pyrrolidinyl)methyl)-1h-benzotriazole-5-carboxamide Hydrochloride
| Molecular Weight | 351.8 g/mol |
|---|---|
| Molecular Formula | C16H22ClN5O2 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | 351.1462027 g/mol |
| Monoisotopic Mass | 351.1462027 g/mol |
| Topological Polar Surface Area | 83.1 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 433 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
ABOUT THIS PAGE
A Limican manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Limican, including repackagers and relabelers. The FDA regulates Limican manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Limican API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Limican manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Limican supplier is an individual or a company that provides Limican active pharmaceutical ingredient (API) or Limican finished formulations upon request. The Limican suppliers may include Limican API manufacturers, exporters, distributors and traders.
click here to find a list of Limican suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Limican Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Limican GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Limican GMP manufacturer or Limican GMP API supplier for your needs.
A Limican CoA (Certificate of Analysis) is a formal document that attests to Limican's compliance with Limican specifications and serves as a tool for batch-level quality control.
Limican CoA mostly includes findings from lab analyses of a specific batch. For each Limican CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Limican may be tested according to a variety of international standards, such as European Pharmacopoeia (Limican EP), Limican JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Limican USP).
LOOKING FOR A SUPPLIER?
